1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Serious adverse events
10-Caliber Coils (n = 106)15-Caliber Coils (n = 104)
Mortality, total (No.) (%)7 (6.6%)2 (1.9%)
 Aneurysm rupture during procedure2 (1.9%)1 (1.0%)
 Stroke, periprocedural2 (1.9%)0
 Stroke, related to SAH at presentation1 (0.9%)0
 Related to SAH during follow-up01 (1.0%)
 Unrelated to aneurysm or its treatment2 (1.9%)0
Morbidity, total (No.) (%)11 (10.4%)5 (4.8%)
 Aneurysm rupture during procedure4 (3.8%)3 (2.9%)
 Stroke6 (5.7%)2 (1.9%)
 SAH during follow-up1 (0.9%)0